Accelirate Launches New Scalable Product for Denials and Appeals Management in Healthcare

AI-driven solution automates denials management while keeping clinicians in control and improving revenue outcomes.

Published on Feb. 11, 2026

Got story updates? Submit your updates here. ›

Accelirate, a leader in intelligent automation and agent-based enterprise solutions, is launching a new product designed to change how healthcare organizations manage denials and appeals. The platform takes a full-lifecycle approach, bringing together intelligent agents to handle tasks like denial intake, classification, documentation gathering, and draft appeal creation, while allowing appeals nurses and reviewers to maintain control over clinical judgment and final decisions.

Why it matters

Denials management has been a manual, time-consuming, and frustrating part of the revenue cycle for healthcare organizations. As denial volumes rise, teams face difficulties managing, leaving recoverable revenue on the table and lacking visibility into denial drivers. Accelirate's new solution aims to address these challenges by automating key tasks while preserving clinical oversight and compliance.

The details

The product is designed with human-in-the-loop governance, allowing intelligent agents to handle time-intensive work while appeals nurses and reviewers remain in control of clinical judgment and final decisions. This enables clinical teams to spend more time reviewing and less time on paperwork. The solution also provides leadership teams with improved visibility through built-in insights that help surface denial trends, identify root causes, and track appeal outcomes.

  • The product will be unveiled during a live virtual event on Wednesday, February 18, 2026 at 10:30 PM (local time).
  • Accelirate plans to launch the new product in February 2026.

The players

Accelirate

A U.S.-based leader in intelligent automation and agent-driven enterprise solutions that helps healthcare and enterprise organizations modernize complex operations, improve outcomes, and drive measurable ROI through practical, scalable automation.

Harsh Thakar

The COO of Accelirate.

Ahmed Zaidi

The CEO and Co-founder of Accelirate.

Got photos? Submit your photos here. ›

What they’re saying

“Denials teams are stretched thin, and the traditional tools haven't kept pace with today's volume and complexity. We built this solution based on how denials actually happen in the real world and across payers, systems, and clinical workflows. It's not just about doing things faster. It's about doing them better, with less strain on people and more confidence in the outcome.”

— Harsh Thakar, COO, Accelirate (EINPresswire)

“At scale, denials management shouldn't require constantly adding headcount. This is about giving organizations a way to grow appeal volume, improve recovery, and reduce burnout without linear cost increases.”

— Ahmed Zaidi, CEO and Co-founder, Accelirate (EINPresswire)

What’s next

The product name and full feature details will be revealed during the live launch event on February 18, 2026.

The takeaway

Accelirate's new solution aims to modernize denials and appeals management in healthcare by automating key tasks while preserving clinical oversight, improving visibility, and reducing the strain on overburdened teams.